Rome is the world capital of the bioeconomy for a couple of days. The International Forum on Industrial Biotechnology and Bioeconomy (IFIB) starts today in the Eternal City and is both physical and digital because of the Covid19 restrictions.
With more than 300 delegates in attendance from approximately 30 different countries from all around the world, the conference truly succeeds one more time in its ambitious aim to be one of the leading bioeconomy event at global level.
Business and policy leaders are sharing in Rome their insights on strengthening the biobased value chain in order to produce smarter, more sustainable products, processes to create new jobs and generate economic growth in the post-covid19 era. To animate the forum will be many presentations divided into different sessions and three round tables focused on Venture Capitals, National Strategies and Green New Deal. IFIB is hosting today also an initiative organized by the European Circular Bioeconomy Fund.
Among the speakers representatives of Clariant, Braskem, Novamont, Stora Enso, Dow, NatureWorks, Versalis, Aquafil, BBI JU, ERC, Neste and many others. IFIB, organized with the support of Lazio Region, is also attracting to Rome many EU research projects, such as Grace, Biovoices, Biobesticide and others.